CURRENT POSSIBILITIES OF ANTI-INFLAMMATORY THERAPY IN PULMONOLOGY
- Authors: Shmelev E.1, Shmelev N.1
-
Affiliations:
- Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, Moscow
- Issue: Vol 23, No 2 (2012)
- Pages: 19
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115317
- ID: 115317
Cite item
Open Access
Access granted
Abstract
The paper gives updates on a basically new direction in anti-inflammatory therapy with the phosphodiesterase 4 inhibitor roflumilast in patients with chronic obstructive pulmonary disease. It describes the mechanisms of action of the drug and indications for its use. The results of clinical trials and the possibility of using roflumilast for other lung diseases are described.
Full Text
About the authors
E. Shmelev
Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, Moscow
Email: eishmelev@mail.ru
Department of Pulmonology
N. Shmelev
Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, MoscowDepartment of Pulmonology
References
Supplementary files
